Recent News

• 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.06.2025 - Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
• 03.04.2025 - TD Cowen 45th Annual Healthcare Conference
• 02.25.2025 - Dynavax to Participate in Upcoming Investor Conferences
• 02.20.2025 - Dynavax Technologies Fourth Quarter and Full Year 2024 Financial Results
• 02.20.2025 - Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
• 02.19.2025 - Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Recent Filings

• 03.06.2025 - 8-K Current report
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 8-K Current report
• 02.20.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 02.20.2025 - 8-K Current report
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.20.2025 - EX-99.1 EX-99.1